ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0396

Quantifying Burden of Uveitis Care for Pediatric Uveitis Patients and Caregivers

Catherine Lavallee1, Samuel Garfinkle2, Devlin Eckardt3, Stefanie Davidson4, Melissa Lerman5, Nicole Reitz6 and Kerry Hurlbut5, 1St. Christopher's Hospital for Children, Philadelphia, PA, 2Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 3Children's Hospital of Philadelphia, Philadelphia, 4University of Pennsylvania/CHOP, Philadelphia, PA, 5Children's Hospital of Philadelphia, Philadelphia, PA, 6Department of Mental Health, St. Louis, MO

Meeting: ACR Convergence 2025

Keywords: Eye Disorders, Patient reported outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0387–0429) Pediatric Rheumatology – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Chronic noninfectious uveitis (CU) in pediatric patients is often asymptomatic and can cause vision loss, requiring frequent ophthalmologist visits and long-term treatment. This survey aimed to evaluate perception of the overall impact of CU on patients and their families and to describe the relative contributions of financial costs, healthcare access, and treatment adherence to perceived burden.

Methods: With input from patient representatives, a questionnaire was developed including ~65 questions: multiple-choice, Likert-scale, and open-ended. It was administered via REDCap at a pediatric tertiary center between April-June 2024. Participants included English-speaking guardians or adult patients (≥ 18 yo) diagnosed with CU < age 18, who received care in a coordinated ophthalmology/rheumatology clinic. Patients were asked to score “overall burden”; to categorize factors (eg. dollars spent per month, commute time to appointments), and to score perceived burdens from each category (cost, travel, obtaining medicine, giving medicine, impact on work/school/family, and emotional concerns). Data was analyzed using descriptive statistics, Wilcoxon rank sum tests, and Spearman’s rank correlations.

Results: A total of 46 participants completed the survey. 93% of respondents (n=43) answered the question of their perceived overall burden of uveitis care. 61% reported a perceived overall burden sentiment of “neutral” while 40% reported “difficult”. Higher burden (difficult vs. neutral) was significantly associated with patient reported higher burdens from categories: cost of care (p = 0.008), burden from travel to appointments (p=0.009), burden on family (p=0.032) and emotional concerns (p=0.04). There was no correlation between burden and participant age. Nearly half of participants were unaware of their uveitis subtype, and many did not know their monthly medical expenses. Spearman correlation confirmed significant positive associations of perceived overall burden with patient reported higher burdens from categories: cost of care (rh=0.48, p=0.001), burden from travel to appointments (rh=0.37, p=0.012), burden on family (rh=0.33, p=0.025), and emotional concerns (rh=0.30, p=0.047).

Conclusion: The study describes the burden faced by pediatric CU patients and their families. Cost and travel requirements were perceived as the greatest contributors. Limitations of this pilot study include it being performed at a single center and survey being restricted to patients in a coordinated uveitis clinic. Further directions include quantifying burden in a larger cohort and evaluating whether these same factors are the greatest contributors.

Supporting image 1Table 1. Cohort demographics.

Supporting image 2Figure 1. Categories Represented in Survey Questions. Each segment in this pie chart represents a category assessed in the survey, including Demographic information, Patient Reported Perceived Overall Burden, Patient Reported Perceived Burden from Specific Categories, Family Impact, Work Impact, School Impact, Burden of Appointments, Uveitis Activity, Medication, Travel for Care, and Cost of Care/Financial Information. The size of each segment corresponds to the proportion of survey questions dedicated to the category.

Supporting image 3Panels a-d: Wilcoxon rank-sum tests of association of Overall burden (x-axis) and burden from individual categories (y-axis). Overall burden: “Considering the ways uveitis affects your life and finances, how difficult is receiving uveitis care on the patient and their family/caretaker(s)? (Note, in this survey we are not focusing on emotional burden)”; scoring: Very easy (1), Easy (2), Neutral (3), Difficult (4), Very Difficult (5). Every dot represents a patient.

Panels e-h: Spearman’s rank correlations of patient reported burden from individual categories (x-axis) and perceived overall burden (y-axis). Burden of individual categories: “Please rank what factors of uveitis care are most burdensome for the patient and guardian”; scoring: Not a Burden (1), Neutral (3), a Great Burden (5). Individual categories include Cost of care (E), Burden from travel to appointments (F), Burden on Family (G), Emotional Concerns (H). Rho: represents strength of correlation. P-value represents statistical significance. Larger dot size represents more patients.


Disclosures: C. Lavallee: None; S. Garfinkle: None; D. Eckardt: None; S. Davidson: None; M. Lerman: None; N. Reitz: None; K. Hurlbut: None.

To cite this abstract in AMA style:

Lavallee C, Garfinkle S, Eckardt D, Davidson S, Lerman M, Reitz N, Hurlbut K. Quantifying Burden of Uveitis Care for Pediatric Uveitis Patients and Caregivers [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/quantifying-burden-of-uveitis-care-for-pediatric-uveitis-patients-and-caregivers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantifying-burden-of-uveitis-care-for-pediatric-uveitis-patients-and-caregivers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology